在三级医院的IgA病中,MEST C评分和治疗反应:描述性的横截面研究
Sushma Thapa1, Mahesh Raj Sigdel2
1Department of Internal Medicine, Bharatpur Hospital, Bharatpur, Chitwan, Nepal.
JNMA; journal of the Nepal Medical Association
|October 6, 2024
概括
在尼泊尔的IgA脏病患者中,MEST-C得分显示了与部分缓解和末期脏病相关的细分型血小板硬化 (S1) 和管状缩 (T1). 更高的间歇性纤维化 (IFTA) 增加了不完全缓解的风险.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 病理学 病理学 病理学
背景情况:
- 全球范围内,免疫球蛋白A (IgA) 脏病是一种主要的血球炎.
- 牛津分类 (MEST-C评分) 预测IgA脏病预后,但其在尼泊尔的使用尚未研究.
研究的目的:
- 评估MEST-C得分在预测尼泊尔IgA脏病患者治疗反应中的有用性.
- 评估影响结果的人口和临床因素.
主要方法:
- 一项描述性的横截面研究包括52名成年IgA脏病患者.
- 分析了脏活检MEST-C得分,人口统计和临床数据.
- 社会科学统计包用于数据分析.
主要成果:
- 分段性淋巴结核硬化 (S1) 和管状缩 (T1) 与更高的部分缓解和进展到末期脏疾病有关.
- 间歇性纤维化/管管缩 (IFTA) 超过25%增加了无法实现完全缓解的风险.
- 淋巴细胞半月 (C1) 显示混合缓解和进展率.
结论:
- MEST-C分数组件,特别是S1和T1/2,在尼泊尔人群中提供预后价值.
- IFTA是预测IgA脏病治疗结果的关键因素.
相关概念视频
Nephrotic Syndrome II : Assessment and Medical Management
2
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
2
Chronic Kidney Disease III: Interprofessional Care
2
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
2


